As reported previously, stage IIIb–IV gastric cardia adenocarcinoma patients tended to express more cyclin D1 compared with stage I–IIIa gastric cardia adenocarcinoma patients 40. This evidence concerns the gene CCND1 and gastric cardia adenocarcinoma.